{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:12:42Z","timestamp":1789560762099,"version":"build-2803163510"},"reference-count":16,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Opsoclonus\u2013myoclonus\u2013ataxia syndrome (OMAS) is a rare immune-mediated neurological disorder in adults and is frequently associated with an underlying malignancy. We report a woman in her sixties presenting with subacute onset opsoclonus and gait ataxia. Diagnostic evaluation identified metastatic carcinoma involving the left axillary lymph nodes. No primary breast lesion was detected on mammography, ultrasonography, positron emission tomography-computed tomography or contrast-enhanced breast MRI. Paraneoplastic antibody panels in both serum and cerebrospinal fluid were negative. Marked neurological improvement was observed following treatment with corticosteroids and intravenous immunoglobulin. This case illustrates an uncommon presentation of antibody-negative paraneoplastic OMAS associated with occult breast carcinoma manifesting solely as axillary nodal disease.<\/jats:p>","DOI":"10.1136\/bcr-2026-273307","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:00:18Z","timestamp":1789560018000},"page":"e273307","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Occult breast carcinoma presenting as paraneoplastic opsoclonus\u2013myoclonus\u2013ataxia syndrome"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5727-1887","authenticated-orcid":false,"given":"Syed Adil","family":"Hassan","sequence":"first","affiliation":[{"name":"Medical Oncology, Apollo Hospitals Guwahati, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7190-0748","authenticated-orcid":false,"given":"Aswini","family":"Bezbaruah","sequence":"additional","affiliation":[{"name":"Internal Medicine, Apollo Hospitals Guwahati, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5705-6822","authenticated-orcid":false,"given":"Dipjyoti","family":"Payeng","sequence":"additional","affiliation":[{"name":"Neurology, Apollo Hospitals Guwahati, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0255-764X","authenticated-orcid":false,"given":"Akriba","family":"Ahmed","sequence":"additional","affiliation":[{"name":"ENT, Apollo Hospitals Guwahati, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2026091605001346000_19.9.e273307.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023009"},{"key":"2026091605001346000_19.9.e273307.2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.2.437"},{"key":"2026091605001346000_19.9.e273307.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.06973"},{"key":"2026091605001346000_19.9.e273307.4","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1990.01410140088014"},{"key":"2026091605001346000_19.9.e273307.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-000-0411-4"},{"key":"2026091605001346000_19.9.e273307.6","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2005.03.520"},{"key":"2026091605001346000_19.9.e273307.7","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1002\/cncr.25197","article-title":"Population-based analysis of occult primary breast cancer with axillary lymph node metastasis","volume":"116","author":"Walker","year":"2010","journal-title":"Cancer"},{"key":"2026091605001346000_19.9.e273307.8","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32080440","article-title":"Seronegative Paraneoplastic Opsoclonus-Myoclonus-Ataxia Syndrome Secondary to Low Volume Endocrine-Sensitive Malignancy of Likely Breast Origin","volume":"32","author":"Berger","year":"2025","journal-title":"Curr Oncol"},{"key":"2026091605001346000_19.9.e273307.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016"},{"key":"2026091605001346000_19.9.e273307.10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026091605001346000_19.9.e273307.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199619010-00001","article-title":"The immunopharmacology of the opsoclonus-myoclonus syndrome","volume":"19","author":"Pranzatelli","year":"1996","journal-title":"Clin Neuropharmacol"},{"key":"2026091605001346000_19.9.e273307.12","first-page":"241","article-title":"The role of MRI in breast cancer screening","volume":"6","author":"Morris","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"2026091605001346000_19.9.e273307.13","doi-asserted-by":"crossref","DOI":"10.1093\/jscr\/rjy365","article-title":"Paraneoplastic opsoclonus-myoclonus syndrome as a rare presentation of breast cancer","volume":"2019","author":"Martins","year":"2019","journal-title":"J Surg Case Rep"},{"key":"2026091605001346000_19.9.e273307.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-021-02436-7","article-title":"Breast cancer-associated opsoclonus-myoclonus syndrome: a case report","volume":"19","author":"Kostoglou","year":"2021","journal-title":"World J Surg Oncol"},{"key":"2026091605001346000_19.9.e273307.15","first-page":"100346","article-title":"A case of opsoclonus-myoclonus syndrome associated with breast cancer","volume":"17","author":"Mohar","year":"2025","journal-title":"Curr Probl Cancer Case Rep"},{"key":"2026091605001346000_19.9.e273307.16","first-page":"1676","article-title":"Immunomodulatory treatment trial for paraneoplastic neurological disorders","volume":"63","author":"Vernino","year":"2004","journal-title":"Neurology"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2026-273307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:00:21Z","timestamp":1789560021000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2026-273307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":16,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,16]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bcr-2026-273307"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2026-273307","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}